Pharmacogenetics of tipifarnib (R115777) transport and metabolism in cancer patients

2004-08-01

Additional Metadata
Keywords	Pharmacogenetics, Polymorphisms, R115777, Tipifarnib
Persistent URL	doi.org/10.1023/B:DRUG.0000026254.97350.fe, hdl.handle.net/1765/66937
Journal	Investigational New Drugs: the journal of new anti-cancer agents
Organisation	Department of Medical Oncology
Citation APA APA Style APA-ALL Style AAA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Sparreboom, A., Marsh, S., Mathijssen, R., Verweij, J.& McLeod, H. (2004). Pharmacogenetics of tipifarnib (R115777) transport and metabolism in cancer patients. Investigational New Drugs: The Journal of New Anti-cancer Agents, 22(3), 285–289.https://doi.org/10.1023/B:DRUG.0000026254.97350.fe

Publication